U.S. Stem Cell, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
U.S. Stem Cell, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q4 2022.
  • U.S. Stem Cell, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2022 was -$192K, a 30.9% increase year-over-year.
  • U.S. Stem Cell, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2022 was -$1.14M, a 1.22% increase year-over-year.
  • U.S. Stem Cell, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.14M, a 1.22% increase from 2021.
  • U.S. Stem Cell, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.15M, a 135% decline from 2020.
  • U.S. Stem Cell, Inc. annual Nonoperating Income (Expense) for 2020 was -$490K, a 17.2% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$1.14M -$192K +$86K +30.9% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-14
Q3 2022 -$1.22M -$169K -$1.23K -0.73% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 -$1.22M -$135K +$77.9K +36.6% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-22
Q1 2022 -$1.3M -$641K -$149K -30.2% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-23
Q4 2021 -$1.15M -$278K -$129K -86.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-14
Q3 2021 -$1.02M -$168K -$5.1K -3.14% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$1.02M -$213K -$112K -112% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
Q1 2021 -$905K -$493K -$415K -534% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 -$490K -$149K -$358K -172% Oct 1, 2020 Dec 31, 2020 10-K/A 2022-07-08
Q3 2020 -$132K -$162K -$114K -237% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$17.7K -$101K +$204K +67% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$222K -$77.7K +$196K +71.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-07-16
Q4 2019 -$418K $209K +$608K Oct 1, 2019 Dec 31, 2019 10-K 2021-07-16
Q3 2019 -$1.03M -$48.2K +$64K +57% Jul 1, 2019 Sep 30, 2019 10-Q 2021-07-16
Q2 2019 -$1.09M -$305K +$116K +27.6% Apr 1, 2019 Jun 30, 2019 10-Q 2021-07-16
Q1 2019 -$1.21M -$274K -$144K -111% Jan 1, 2019 Mar 31, 2019 10-Q 2021-07-16
Q4 2018 -$1.06M -$399K -$594K -305% Oct 1, 2018 Dec 31, 2018 10-K 2021-07-16
Q3 2018 -$468K -$112K -$238K -190% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$231K -$421K +$146K +25.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$377K -$130K +$2.3M +94.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$2.68M $195K +$2.06K +1.07% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$2.68M $125K +$786K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$3.46M -$567K -$473K -504% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$2.99M -$2.43M -$2.08M -596% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$911K $193K +$498K Oct 1, 2016 Dec 31, 2016 10-K/A 2018-04-26
Q3 2016 -$1.41M -$660K -$803K -563% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$606K -$93.9K -$1.46M -107% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $855K -$349K -$109K -45.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 $964K -$305K -$283K -1252% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 $1.25M $143K +$149K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $1.1M $1.37M +$1.36M +20478% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-02
Q1 2015 -$263K -$241K -$1.54M -119% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 $1.28M -$22.6K +$63.3K +73.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-08
Q3 2014 $1.21M -$6.5K +$73.1K +91.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $1.14M $6.64K +$165K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-03
Q1 2014 $975K $1.3M +$1.29M +10550% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 -$312K -$85.9K +$418K +82.9% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$729K -$79.6K +$241K +75.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$970K -$158K +$81.8K +34.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-01
Q1 2013 -$1.05M $12.2K +$430K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 -$1.48M -$503K -$171K -51.5% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-25
Q3 2012 -$1.31M -$320K +$572K +64.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$1.88M -$240K +$160K +40% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$2.04M -$418K -$11.5K -2.82% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$2.03M -$332K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-29
Q3 2011 -$893K -$626K -234% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$400K -$347K -656% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$406K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q3 2010 -$267K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$52.9K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.